🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To explore what is driving heart-rate increases after dosing with mirabegro...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01284868
Treatments Being Tested
The study is intended to test efficacy, safety and tolerability of two dose...
Status
Completed
Location
Multiple Locations
Start Date
2008-04-28
Trial ID
NCT00689104
Treatments Being Tested
Mirabegron (Myrbetriq®, Astellas) is a highly specific and well-tolerated ß...
Status
Recruiting
Location
University of Kentucky
Start Date
2020-12-07
Trial ID
NCT04666636
Treatments Being Tested
The purpose of the study was to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Site US01009
Start Date
2016-06-13
Trial ID
NCT02757768
Treatments Being Tested
The objective of this pilot study is to assess whether Myrbetriq™ will impr...
Status
Terminated
Location
SIUSOM - Division of Urology
Start Date
2015-05
Trial ID
NCT02462837
Treatments Being Tested
The primary objective of the study was to investigate the efficacy of mirab...
Status
Completed
Location
Site JP81046
Start Date
2016-01-25
Trial ID
NCT02656173
Treatments Being Tested
To study the impact of mirabegron, a B3-adrenoceptor agonist, in the treatm...
Status
Unknown
Location
Urology and nephrology center
Start Date
2018-08-01
Trial ID
NCT03600766
Treatments Being Tested
Background: Obesity and related illnesses cause at least 2.8 million death...
Status
Not Yet Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2026-09-02
Trial ID
NCT05713799
Treatments Being Tested
An 8-week randomized, controlled, pilot clinical trial of Mirabegron compar...
Status
Completed
Location
University of California, San Francisco
Start Date
2016-02
Trial ID
NCT02436889
Treatments Being Tested
The proportion of male patients who participated in the phase III study of ...
Status
Unknown
Location
Soon Chun Hyang University Hospital Bucheon
Start Date
2015-02
Trial ID
NCT02361502
Treatments Being Tested